COLUMBIA, SC--(Marketwire - October 02, 2008) - BDI, a national leader in the distribution of biopharmaceutical products, announced that sales for the third quarter of 2008 rose thirty-seven percent (37%) in comparison to the same time period in 2007. The current rate of sales represents revenue growth pacing in excess of twenty-six percent (26%) over last year. With historically strong fourth quarter sales, BDI projects that year end revenues, which have grown at an average rate of twenty-three percent (23%) per year from 2004 - 2007, will surpass expectations for the 2008 fiscal year.
